Name: | Description: | Size: | Format: | |
---|---|---|---|---|
810.08 KB | Adobe PDF |
Advisor(s)
Abstract(s)
We studied the antibacterial and antifungal activity of Cymbopogon citratus. These properties were studied on hospital isolated multidrug resistant strains Staphylococcus aureus, Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli, Klebsiella pneumonia and their respective ATCC control strains. Pathogenic Candida albicans, Candida parapsilosis, and Candida tropicalis were also tested. Results of the present investigation provide evidence that the EO of Cymbopogon citratus could have a potential application in the treatment and prevention of diseases caused by Staphylococcus aureus methicillin-resistant strains and by vancomicin-resistant Staphylococcus epidermidis. Cymbopogon citratus EO is also effective against Candida albicans as well as the emerging Candida parapsilosis and Candida tropicalis pointing to its usefulness as an antifungal agent.
Description
Keywords
Antioxidants Non-albicans-Candida species Gram-positive bacteria Cymbopogon citratus EO Multi-drug resistant bacteria
Citation
Soares, M.O., Vinha, A.F., Barreira, S.V.P., Coutinho, F., Aires-Gonçalves, S., Oliveira, M.B.P.P., Pires, P.C., Castro, A. 2013. Cymbopogon citratus EO antimicrobial activity against multi-drug resistant Gram-positive strains and non-albicans-Candida species, In: Microbial pathogens and strategies for combating them: science, technology and education. Vol. 2. A. Méndez-Vilas Ed., Formatex Research Center, Spain. pp. 1081-1086. ISBN: 978-84-942134-0-3.
Publisher
Formatex Research Center